Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of IFPMA and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR

IFPMA

Geneva, Switzerland
VISIT WEBSITE
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) is a global, non-profit, non-governmental trade association based in Geneva, Switzerland. It represents the research-based pharmaceutical industry, including biotechnology and vaccine sectors, at the international level and maintains official relations with the United Nations. IFPMA champions pharmaceutical innovation and drives policy that supports the research, development, and delivery of health technologies. The organization works closely with public health stakeholders, including the World Health Organization (WHO), to create sustainable solutions that advance global health and improve patient access to medicines and vaccines.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Trade Association
SIZE & FINANCIALS
Employees:1-50
Founded:1968
Ownership:nonprofit
Status:operating
PIPELINE
Modalities:Small molecule, Vaccines, Cell therapy, Gene therapy
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:World Health Organization (WHO), United Nations, World Intellectual Property Organization (WIPO), World Trade Organization (WTO)
COMPETITION
Position:Leader
LEADERSHIP
Key Executives:
Thomas Schinecker - President (CEO, Roche Group)
David Reddy - Director General
LINKS
Website:ifpma.org
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with IFPMA. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.